• For suppression of thrombus/embolus formation in angina pectoris (chronic stable angina pectoris, unstable angina pectoris), myocardial infarction, and ischemic cerebrovascular disorders (transient ischemic attack [TIA], cerebral infarction) or for suppression of thrombus/embolus formation after coronary artery bypass grafting (CABG) or percutaneous transluminal coronary angioplasty (PTCA).

          The usual adult dosage for oral use is 100 mg of aspirin once daily.

          The dose may be increased up to 300 mg according to symptoms.

• For Kawasaki's disease (including cardiovascular sequelae due to Kawasaki's disease)

          For patients with pyrexia during the acute phase of the disease, 30 to 50 mg/kg (body weight)/day of aspirin is administered orally in 3 divided doses. For patients not presenting with pyrexia   during the convalescent phase to chronic phase, 3 to 5 mg/kg (body weight)/day of aspirin is administered orally once daily.

          The dosage may be adjusted according to the patient's symptom.